Blood group antibody detection
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Remaining anticoagulated venous whole blood samples and serum samples collected during routine clinical testing in various clinical trial centers; 2. For anticoagulant venous whole blood samples, the anticoagulant used can be EDTA, citrate or heparin sodium; 3. The visual sample volume shall not be less than 1 mL; 4. Sample validity period: Samples stored at 2 - 8°C, within 48 hours after collection;
Exclusion criteria
Exclusion criteria: 1 Samples of infants less than 4 months old and elderly people over 65 years old; 2. Samples with severe hemolysis, lipemia, turbidity, and contamination; 3 Samples that cannot be tested due to insufficient actual sample size; 4. Samples from patients with tumors, leukemia, aplastic anemia, multiple myeloma, Parkinson's disease, myelofibrosis, hematopoietic stem cell transplantation (including bone marrow transplantation), liver disease, tuberculosis, etc. that seriously affect blood group antibody detection; 5 The sample information is incomplete and should at least include: gender, age, sampling date, sample type, clinical diagnosis information and patient/sample unique identification (such as medical record number/medical record number/outpatient visit number, patient ID, sample number, etc.).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| reverse blood grouping;Blood type antibody titer; | — |
Countries
China
Contacts
The 909th Hospital of the Joint Logistic Support Force of PLA